glp 1 for diabetes type 2 Targeting GLP-1, GIP & GCG in Obesity and Research Clinical Focus on GLP-1 Agonists
Description
Triple fixed drug combinations in type 2 diabetes
A sudden release of certain cytokines can cause systemic inflammation, leading to that achy feeling often associated with the flu
Also exenatide is available in a once weekly version, in which the molecule is slowly liberated from a subcutaneously injected depot
Read More Ready to lose weight and feel great
Safety Profile and Tolerability Concerns Gastrointestinal Adverse Effects While GLP-1RAs are effective in managing obesity, their use is associated with gastrointestinal side effects and rare but serious adverse events [42] [43] [44]
